{"filing":{"accession_number":"0001731122-26-000910","cik":"0001553788","ticker":"SBEVW","company_name":"SPLASH BEVERAGE GROUP, INC.","form":"8-K","filing_date":"2026-07-06","report_date":null,"primary_document":"e7759_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000910/e7759_8-k.htm"},"events":[{"id":16152,"run_id":14413,"accession_number":"0001731122-26-000910","anchor_item_number":"7.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"summary":"Splash Beverage Group entered into an exclusive global licensing agreement with Argent BioPharma Limited to acquire worldwide rights to CannEpil®, a cannabinoid-based epilepsy therapeutic. The transaction includes $5.5 million in newly issued preferred equity consideration, a $1 million strategic investment commitment, and represents a material acquisition of intellectual property and commercial rights that aligns with the company's stated strategic transformation toward a cannabinoid biopharmaceutical platform. This constitutes a material acquisition activity under Item 1.01/2.01 framework.","company_name":"SPLASH BEVERAGE GROUP, INC.","ticker":"SBEVW","filing_date":"2026-07-06","form":"8-K","submitted_at":null,"items":[{"id":14164,"accession_number":"0001731122-26-000910","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"Splash Beverage Group entered into an exclusive global licensing agreement with Argent BioPharma Limited to acquire worldwide rights to CannEpil®, a cannabinoid-based epilepsy therapeutic. The transaction includes $5.5 million in newly issued preferred equity consideration, a $1 million strategic investment commitment, and represents a material acquisition of intellectual property and commercial rights that aligns with the company's stated strategic transformation toward a cannabinoid biopharmaceutical platform. This constitutes a material acquisition activity under Item 1.01/2.01 framework.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-06T12:47:59.997985+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14164,"accession_number":"0001731122-26-000910","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"Splash Beverage Group entered into an exclusive global licensing agreement with Argent BioPharma Limited to acquire worldwide rights to CannEpil®, a cannabinoid-based epilepsy therapeutic. The transaction includes $5.5 million in newly issued preferred equity consideration, a $1 million strategic investment commitment, and represents a material acquisition of intellectual property and commercial rights that aligns with the company's stated strategic transformation toward a cannabinoid biopharmaceutical platform. This constitutes a material acquisition activity under Item 1.01/2.01 framework.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-06T12:47:59.997985+00:00","company_name":"SPLASH BEVERAGE GROUP, INC.","ticker":"SBEVW","filing_date":"2026-07-06"}]}